Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Journal of Bone and Mineral Metabolism
Published in: Journal of Bone and Mineral Metabolism 3/2006

01-05-2006 | ORIGINAL ARTICLE

The sample size required for intervention studies on fracture prevention can be decreased by using a bone resorption marker in the inclusion criteria: prospective study of a subset of the Nagano Cohort, on behalf of the Adequate Treatment of Osteoporosis (A-TOP) Research Group

Authors: Masataka Shiraki, Tatsuhiko Kuroda, Toshitaka Nakamura, Masao Fukunaga, Takayuki Hosoi, Hajime Orimo, Kuniyoshi Makino

Published in: Journal of Bone and Mineral Metabolism | Issue 3/2006

Login to get access
Metadata
Title
The sample size required for intervention studies on fracture prevention can be decreased by using a bone resorption marker in the inclusion criteria: prospective study of a subset of the Nagano Cohort, on behalf of the Adequate Treatment of Osteoporosis (A-TOP) Research Group
Authors
Masataka Shiraki
Tatsuhiko Kuroda
Toshitaka Nakamura
Masao Fukunaga
Takayuki Hosoi
Hajime Orimo
Kuniyoshi Makino
Publication date
01-05-2006
Publisher
Springer-Verlag
Published in
Journal of Bone and Mineral Metabolism / Issue 3/2006
Print ISSN: 0914-8779
Electronic ISSN: 1435-5604
DOI
https://doi.org/10.1007/s00774-005-0675-7

Other articles of this Issue 3/2006

Journal of Bone and Mineral Metabolism 3/2006 Go to the issue

EDITORIAL

Following in a proud tradition of leadership

ORIGINAL ARTICLE

Assessment of linkage and association of 13 genetic loci with bone mineral density

ORIGINAL ARTICLE

Combined intervention of dietary soybean proteins and swim training: effects on bone metabolism in ovariectomized rats

ORIGINAL ARTICLE

Involvement of Notch signaling in initiation of prechondrogenic condensation and nodule formation in limb bud micromass cultures

ORIGINAL ARTICLE

High-turnover osteoporosis is induced by cyclosporin A in rats

ORIGINAL ARTICLE

Bisphosphonate pretreatment attenuates hungry bone syndrome postoperatively in subjects with primary hyperparathyroidism
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits